Zobrazeno 1 - 10
of 433
pro vyhledávání: '"Sirico, M."'
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond
Autor:
Sirico, M., Jacobs, F., Molinelli, C., Nader-Marta, Guilherme, Debien, V., Dewhurst, H. Faith, Palleschi, M., Merloni, F., Gianni, C., De Giorgi, U., de Azambuja, Evandro
Publikováno v:
In Critical Reviews in Oncology / Hematology August 2024 200
Autor:
Abbasian MH; Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran., Sobhani N; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Sisakht MM; Faculty of Pharmacy, Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran., D'Angelo A; Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AX, UK., Sirico M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Roudi R; Molecular Imaging Program at Stanford, Department of Radiology, Stanford University, Stanford, CA, USA. Raheleroudi@gmail.com.
Publikováno v:
Stem cell reviews and reports [Stem Cell Rev Rep] 2024 Oct 21. Date of Electronic Publication: 2024 Oct 21.
Autor:
Merloni F; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy. filippo.merloni@irst.emr.it., Palleschi M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Gianni C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Sirico M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Serra R; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Casadei C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Sarti S; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Cecconetto L; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Menna GD; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Mariotti M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Maltoni R; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Montanari D; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Romeo A; Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy., Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Via P.Maroncelli 40, 47014, Meldola, Italy.
Publikováno v:
Clinical & experimental metastasis [Clin Exp Metastasis] 2024 Sep 23. Date of Electronic Publication: 2024 Sep 23.
Autor:
Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.; Medical Oncology Department, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain., Sirico M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' 47014, Meldola, Italy., Loddo M; Oncologica UK Ltd, Cambridge CB10 1XL, United Kingdom., Williams GH; Oncologica UK Ltd, Cambridge CB10 1XL, United Kingdom., Hardisty KM; Oncologica UK Ltd, Cambridge CB10 1XL, United Kingdom., Scorer P; Oncologica UK Ltd, Cambridge CB10 1XL, United Kingdom., Thatcher R; Oncologica UK Ltd, Cambridge CB10 1XL, United Kingdom., Rivera P; Medical Oncology Department, Hospital Clinic of Barcelona, 08036 Barcelona, Spain., Milani M; Department of Medical, Surgical and Health Sciences, University of Trieste, 34147, Trieste, Italy., Strina C; Department of Medical, Surgical and Health Sciences, University of Trieste, 34147, Trieste, Italy., Ferrero G; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, 26100, Cremona, Italy., Ungari M; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, 26100, Cremona, Italy., Bottin C; Department of Medical, Surgical and Health Sciences, University of Trieste, 34147, Trieste, Italy., Zanconati F; Department of Medical, Surgical and Health Sciences, University of Trieste, 34147, Trieste, Italy., de Manzini N; Department of Medical, Surgical and Health Sciences, University of Trieste, 34147, Trieste, Italy., Aguggini S; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, 26100, Cremona, Italy., Tancredi R; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, 26100, Cremona, Italy., Fiorio E; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, 37134, Verona, Italy., Fioravanti A; Pathology Unit, ASST Cremona, 26100, Cremona, Italy., Scaltriti M; Neurosurgery Unit, ASST Cremona, 26100, Cremona, Italy.; AstraZeneca, Gaithersburg, MD 20876, United States., Generali D; Department of Medical, Surgical and Health Sciences, University of Trieste, 34147, Trieste, Italy.; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, 26100, Cremona, Italy.
Publikováno v:
The oncologist [Oncologist] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.
Autor:
Sirico M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Virga A; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Conte B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Urbini M; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Ulivi P; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gianni C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Merloni F; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Palleschi M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gasperoni M; Breast Surgery Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Forlì, Italy., Curcio A; Breast Surgery Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Forlì, Italy., Saha D; Department of Surgery and Cancer, Imperial College London, London, UK., Buono G; Department of Breast and Thoracic Oncology, National Cancer Institute, Fondazione G. Pascale, Naples, Italy., Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine, University of Barcelona, Barcelona, Spain., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: schettini@recerca.clinic.cat.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Aug; Vol. 200, pp. 104308. Date of Electronic Publication: 2024 Jun 13.
Autor:
Corona, S.P., Roviello, G., Strina, C., Milani, M., Madaro, S., Zanoni, D., Allevi, G., Aguggini, S., Cappelletti, M.R., Francaviglia, M., Azzini, C., Cocconi, A., Sirico, M., Bortul, M., Zanconati, F., Giudici, F., Rosellini, P., Meani, F., Pagani, O., Generali, D.
Publikováno v:
In The Breast August 2019 46:19-24
Autor:
Massy Z. A., Chesnaye N. C., Larabi I. A., Dekker F. W., Evans M., Caskey F. J., Torino C., Porto G., Szymczak M., Drechsler C., Wanner C., Jager K. J., Alvarez J. C., Schneider A., Torp A., Iwig B., Perras B., Marx C., Blaser C., Emde C., Krieter D., Fuchs D., Irmler E., Platen E., Schmidt-Gurtler H., Schlee H., Naujoks H., Schlee I., Casar S., Beige J., Rothele J., Mazur J., Hahn K., Blouin K., Neumeier K., Anding-Rost K., Schramm L., Hopf M., Wuttke N., Frischmuth N., Ichtiaris P., Kirste P., Schulz P., Aign S., Biribauer S., Manan S., Roser S., Heidenreich S., Palm S., Schwedler S., Delrieux S., Renker S., Schattel S., Stephan T., Schmiedeke T., Weinreich T., Leimbach T., Stovesand T., Bahner U., Seeger W., Cupisti A., Sagliocca A., Ferraro A., Mele A., Naticchia A., Cosaro A., Ranghino A., Stucchi A., Pignataro A., De Blasio A., Pani A., Tsalouichos A., Bellasi A., Raffaele Di Iorio B., Butti A., Abaterusso C., Somma C., D'Alessandro C., Zullo C., Pozzi C., Bergamo D., Ciurlino D., Motta D., Russo D., Favaro E., Vigotti F., Ansali F., Conte F., Cianciotta F., Giacchino F., Cappellaio F., Pizzarelli F., Greco G., Bigatti G., Marinangeli G., Cabiddu G., Fumagalli G., Caloro G., Piccoli G., Capasso G., Gambaro G., Tognarelli G., Bonforte G., Conte G., Toscano G., Del Rosso G., Capizzi I., Baragetti I., Oldrizzi L., Gesualdo L., Biancone L., Magnano M., Ricardi M., Di Bari M., Laudato M., Luisa Sirico M., Ferraresi M., Provenzano M., Malaguti M., Palmieri N., Murrone P., Cirillo P., Dattolo P., Acampora P., Nigro R., Boero R., Scarpioni R., Sicoli R., Malandra R., Savoldi S., Bertoli S., Borrelli S., Maxia S., Maffei S., Mangano S., Cicchetti T., Rappa T., Palazzo V., De Simone W., Schrander A., Van Dam B., Siegert C., Gaillard C., Beerenhout C., Verburgh C., Janmaat C., Hoogeveen E., Hoorn E., Boots J., Boom H., Eijgenraam J. -W., Kooman J., Rotmans J., Vogt L., Raasveld M., Vervloet M., Van Buren M., Van Diepen M., Leurs P., Voskamp P., Blankestijn P., Van Esch S., Boorsma S., Berger S., Konings C., Aydin Z., Musiala A., Szymczak A., Olczyk E., Augustyniak-Bartosik H., Miskowiec-Wisniewska I., Manitius J., Pondel J., Jedrzejak K., Nowanska K., Nowak L., Durlik M., Dorota S., Nieszporek T., Heleniak Z., Jonsson A., Blom A. -L., Rogland B., Wallquist C., Vargas D., Dimeny E., Sundelin F., Uhlin F., Welander G., Bascaran Hernandez I., Grontoft K. -C., Stendahl M., Svensson M., Heimburger O., Kashioulis P., Melander S., Almquist T., Jensen U., Woodman A., McKeever A., Ullah A., McLaren B., Harron C., Barrett C., O'Toole C., Summersgill C., Geddes C., Glowski D., McGlynn D., Sands D., Roy G., Hirst G., King H., McNally H., Masri-Senghor H., Murtagh H., Rayner H., Turner J., Wilcox J., Berdeprado J., Wong J., Banda J., Jones K., Haydock L., Wilkinson L., Carmody M., Weetman M., Joinson M., Dutton M., Matthews M., Morgan N., Bleakley N., Cockwell P., Roderick P., Mason P., Kalra P., Sajith R., Chapman S., Navjee S., Crosbie S., Brown S., Tickle S., Mathavakkannan S., Kuan Y.
Publikováno v:
the EQUAL study investigators 2022, ' The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease ', Clinical kidney journal, vol. 15, no. 4, pp. 798-807 . https://doi.org/10.1093/ckj/sfab262
Clinical kidney journal, 15(4), 798-807. Oxford University Press
Massy, Z A, Chesnaye, N C, Larabi, I A, Dekker, F W, Evans, M & Caskey, F J 2021, ' The relationship between uremic toxins and symptoms in older men and women with advanced Chronic Kidney Disease ', Clinical Kidney Journal . https://doi.org/10.1093/ckj/sfab262
Clinical kidney journal, 15(4), 798-807. Oxford University Press
Massy, Z A, Chesnaye, N C, Larabi, I A, Dekker, F W, Evans, M & Caskey, F J 2021, ' The relationship between uremic toxins and symptoms in older men and women with advanced Chronic Kidney Disease ', Clinical Kidney Journal . https://doi.org/10.1093/ckj/sfab262
Background Patients with stage 4/5 chronic kidney disease (CKD) suffer from various symptoms. The retention of uremic solutes is thought to be associated with those symptoms. However, there are relatively few rigorous studies on the potential links b
Autor:
Zattarin E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mariani L; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Menichetti A; Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy., Leporati R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Provenzano L; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ligorio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy., Fucà G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lobefaro R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lalli L; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vingiani A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Nichetti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Griguolo G; Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.; Department of Surgery, Oncology and Gastroenterology-DiSCOG, University of Padova, Padova, Italy., Sirico M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Bernocchi O; Farmacia Ospedaliera ASST Cremona, Cremona, Lombardia, Italy., Marra A; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Corti C; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy., Zagami P; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy., Agostinetto E; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Institut Jules Bordet and l'Université Libre de Bruxelles, Bruxelles, Belgium., Jacobs F; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Di Mauro P; Medical Oncology Unit, ASST Spedali Civili, Brescia, Italy., Presti D; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sposetti C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giorgi CA; Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy., Guarneri V; Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.; Department of Surgery, Oncology and Gastroenterology-DiSCOG, University of Padova, Padova, Italy., Pedersini R; Medical Oncology Unit, ASST Spedali Civili, Brescia, Italy., Losurdo A; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Generali D; Breast Cancer Unit & Translational Research Unit, ASST Cremona, Cremona, Italy.; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy., Pruneri G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., de Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Dieci MV; Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.; Department of Surgery, Oncology and Gastroenterology-DiSCOG, University of Padova, Padova, Italy., Vernieri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan 20133, Italy IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Dec 20; Vol. 15, pp. 17588359231204857. Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2023).
Autor:
Sobhani N; Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX, 77030, USA. NSobhani@mdanderson.org., Mondani G; Royal Infirmary Hospital, Foresterhill Health Campus, Foresterhill Rd, Aberdeen, AB25 2ZN, UK., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy., Catalano M; Royal Infirmary Hospital, Foresterhill Health Campus, Foresterhill Rd, Aberdeen, AB25 2ZN, UK., Sirico M; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola, Italy., D'Angelo A; Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AX, UK., Scaggiante B; Department of Life Sciences, University of Trieste, 34127, Trieste, Italy., Generali D; Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127, Trieste, Italy.; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, 26100, Cremona, Italy.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Nov; Vol. 72 (11), pp. 3427-3444. Date of Electronic Publication: 2023 Aug 29.
Autor:
Debien V; Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium. Electronic address: veronique.debien@hubruxelles.be., Marta GN; Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium., Agostinetto E; Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium., Sirico M; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Jacobs F; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Via Manzoni 56, Rozzano, 20089 Milan, Italy., Molinelli C; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Moreau M; Unité de Gestion de l'Information, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Paesmans M; Unité de Gestion de l'Information, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Santoro A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Via Manzoni 56, Rozzano, 20089 Milan, Italy., Taylor D; CHU UCL Namur Sainte Elisabeth, Namur, Belgium., Duhoux FP; Cliniques universitaires Saint-Luc, Brussels, Belgium., Botticelli A; Dipartimento di Scienze Radiologiche, Oncologiche e Anatomopatologiche, Università di Roma Sapienza, Rome, Italy., Barchiesi G; Dipartimento di Scienze Radiologiche, Oncologiche e Anatomopatologiche, Università di Roma Sapienza, Rome, Italy., Speranza I; Dipartimento di Scienze Radiologiche, Oncologiche e Anatomopatologiche, Università di Roma Sapienza, Rome, Italy., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Department of Oncology, KU Leuven - University of Leuven, Leuven, Belgium., Azambuja E; Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium., Piccart M; Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Oct; Vol. 190, pp. 104089. Date of Electronic Publication: 2023 Aug 09.